Abstract

Abstract Little is understood of the molecular mechanisms by which fibrotic diseases such as in Scleroderma, are manifested by interleukins (IL) 4 and 13. Studies support a role for the JNK signaling pathway via transcription factors c-Jun and ATF2, being involved in activating the collagen promoter and translation of the collagen gene. To examine the role of JNK signaling in IL-4/IL-13-induced collagen gene activation, we transfected human fibroblasts with a luciferase reporter plasmid under control of the α2(I) collagen promoter to assess JNK signaling on type I collagen promoter activity. We reveal a critical role for JNK 1 in IL-4/IL-13-induced collagen promoter activity subsequent to ectopic expression of c-Jun and ATF2. In contrast, introduction of a dominant negative (dn) mutant reduces basal and cytokine-induced promoter activity. We demonstrate that the JNK signaling pathway leading to the activation of the collagen gene in fibroblasts is effective not only for TGF-β signaling but also for IL-4/IL-13 signaling.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.